Pfizer Temporarily Halts Premarin Vaginal Cream in India Amid Supply Issues
Pfizer has temporarily discontinued Premarin Vaginal Cream in India due to supply challenges, with minimal financial impact anticipated. The product, used in hormone replacement therapy, faces an uncertain resumption timeline as the company actively works to resolve supply constraints and explore options to restore availability in the market.
*this image is generated using AI for illustrative purposes only.
Pfizer has temporarily discontinued Premarin Vaginal Cream in India due to supply challenges, with the company indicating that the financial impact of this decision is expected to be minimal. The company is currently exploring options to resume the supply of this product in the market as soon as possible.
Impact on Product Availability
The decision affects the availability of Premarin Vaginal Cream, a medication used in hormone replacement therapy. The key details surrounding this development are outlined below:
| Parameter: | Details |
|---|---|
| Product: | Premarin Vaginal Cream |
| Market Affected: | India |
| Reason: | Supply challenges |
| Financial Impact: | Minimal |
| Supply Resumption Timeline: | Not specified |
Company Response
Pfizer has not provided a specific timeline for when the supply will resume. The company is actively working to address the supply constraints and has stated that further updates regarding the resumption of supply are expected once the situation stabilizes.
Historical Stock Returns for Pfizer
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.34% | -3.02% | +2.91% | -1.42% | -13.89% | -17.38% |
What specific supply chain factors are contributing to the discontinuation of Premarin Vaginal Cream in India?
How might competitors in the hormone replacement therapy market capitalize on this temporary gap in supply?
Could this supply disruption indicate broader challenges for Pfizer's product portfolio in emerging markets?
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
